Search Results 481-490 of 27238 for prostate cancer
When Bruce McVety's prostate cancer returned after a seven-year remission, his doctor suggested he go to Mayo Clinic to receive a test that wasn't available ...
A Study of Carboplatin, Cabazitaxel and Abiraterone in High Volume Metastatic Castration Sensitive Prostate Cancer (CASCARA) · Overview · Participation ...
Findings will help identify patients with breast, ovarian, pancreatic or prostate cancer who may benefit from targeted therapies. ROCHESTER, Minn.
It is used to treat some cases of prostate cancer. Estramustine is a combination of two medicines, an estrogen and mechlorethamine. The way that ...
National Comprehensive Cancer Network (NCCN) (Prostate Cancer version 4.2022) low- to intermediate-risk prostate adenocarcinoma; Eastern Cooperative Oncology ...
About this study. This is a single patient study of an investigational drug CPI-613 for treatment of metastatic prostate cancer. Participation eligibility.
99mTc-MIP-1404 is a radioactive diagnostic imaging agent indicated for imaging men with newly diagnosed prostate cancer whose biopsy indicates a histopathologic ...
... prostate cancer. HoLEP offers faster recovery and symptom relief than traditional prostate surgery. Rarely, a second HoLEP procedure may be needed. Read ...
... Prostate Cancer: RADIOpharmaceutical DOSimetry Evaluation (RADIODOSE) Study. Rochester, Minn. The purpose of the study is to assess and evaluate dosimetry ...
This is an open label, phase I/II, multi-center study in adult participants with metastatic hormone sensitive prostate cancer (mHSPC) and with metastatic ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Give by Dec. 31 to multiply your impact 3×.